Mukka Proteins shareholders approve ₹470 crore warrant issue

1 min read     Updated on 14 Jul 2026, 02:55 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Mukka Proteins secured shareholder approval for a ₹470 crore preferential issue of warrants at ₹23.50 each. The resolution passed with 99.96% support, with proceeds earmarked for working capital and expansion.

powered bylight_fuzz_icon
44882117

*this image is generated using AI for illustrative purposes only.

Mukka Proteins shareholders have approved the issuance of 2,00,00,000 convertible warrants, aggregating up to ₹470 crore, through a postal ballot. The special resolution was passed with 99.96% of the valid votes cast in favour, deemed approved on July 12, 2026. The approval follows a corrigendum issued on July 06, 2026, which clarified the utilization of proceeds and pricing basis following observations from the National Stock Exchange of India Limited and BSE Limited.

The preferential issue involves the issuance of warrants at a price of ₹23.50 per warrant. The proceeds are proposed to be allocated across working capital requirements, business expansion, and general corporate purposes. The company stated that the allocation provides flexibility to support long-term growth and operational scale.

Sr. no Purpose/Object(s) of the Preferential Issue Estimated amount to be utilized for each of the Objects (Amount in Rs.) Tentative timeline for utilization of issue proceeds from the date of receipt of funds
1 Working Capital Requirements Rs. 35,00,00,000 As estimated by management
2 Funding Business Expansion Plans Rs. 5,00,00,000 Entire proceeds utilized within 24 months
3 General Corporate Purposes Rs. 7,00,00,000
Total Rs. 47,00,00,000/-

Voting Results

The remote e-voting process commenced on June 13, 2026, and concluded on July 12, 2026. A total of 22,01,79,675 votes were cast in favour of the resolution, while 82,433 votes were cast against it. The scrutinizer's report, dated July 13, 2026, confirmed that no requests were received from members seeking modification of their votes following the corrigendum.

Pricing and Valuation

The issue price of ₹23.50 per warrant was determined based on the higher of the floor price calculated under Regulation 164(1) of the SEBI ICDR Regulations and the fair value determined by an independent registered valuer. The floor price was calculated at ₹23.18 per equity share, derived from the 90-day volume weighted average price (VWAP) on the NSE. The fair value, assessed by Ms. Kavita Joshi, Chartered Accountant and Registered Valuer, was determined at ₹18.14 per share.

Historical Stock Returns for Mukka Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
-2.25%-0.85%-2.82%+5.68%-20.77%-44.47%

What specific business expansion initiatives will the ₹50 crore allocation target?

How will the conversion of these warrants impact the company's earnings per share in the long term?

What are the expected operational efficiencies or revenue growth resulting from the increased working capital?

Mukka Proteins grants Rs 9.10 Cr loan to subsidiary at 8% interest

1 min read     Updated on 12 Jul 2026, 10:12 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Mukka Proteins Limited has sanctioned an unsecured loan of up to Rs 9.10 crore to its subsidiary United Gulf Fishery Products LLC to address urgent business commitments. The loan carries an interest rate of 8% per annum and a tenure of five years from the date of disbursal. As of July 9, 2026, the amount outstanding under this facility is Rs 3,01,22,744.17.

powered bylight_fuzz_icon
45159691

*this image is generated using AI for illustrative purposes only.

Mukka Proteins Limited has entered into a loan agreement with its subsidiary, United Gulf Fishery Products LLC, to provide financial assistance for urgent business commitments. The company will extend an unsecured loan of up to Rs 9.10 crore to the subsidiary at an interest rate of 8% per annum. The tenure for the loan is set at five years from the date of disbursal.

The loan agreement was executed on July 9, 2026. As of the date of disclosure, the total amount outstanding under this facility stands at Rs 3,01,22,744.17. The transaction is classified as a related party transaction and has been conducted on an arm’s length basis.

Mukka Proteins holds a 68% stake in United Gulf Fishery Products LLC. The disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023.

Key Details of the Loan Agreement

Particulars Details
Lender Mukka Proteins Limited
Borrower M/s. United Gulf Fishery Products LLC
Nature of Loan Unsecured loan
Amount of Loan Up to Rs 9.10 crore
Date of Execution July 9, 2026
Interest Rate 8% per annum
Tenure 5 years from date of disbursal
Amount Outstanding Rs 3,01,22,744.17

The filing was signed by Mehaboobsab Mahmadgous Chalyal, Company Secretary & Compliance Officer of Mukka Proteins Limited.

Historical Stock Returns for Mukka Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
-2.25%-0.85%-2.82%+5.68%-20.77%-44.47%

What specific urgent business commitments is United Gulf Fishery Products LLC addressing with this loan?

How will this loan impact Mukka Proteins' liquidity and capital allocation strategy over the next five years?

What are the expected revenue or operational benefits for the subsidiary that will justify the 8% interest cost?

More News on Mukka Proteins

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-20.77%